Lingling Qin Selected Research

Lingling Qin Research Topics

Disease

10	Body Weight (Weight, Body) 12/2022 - 09/2012
8	Insulin Resistance 11/2022 - 09/2012
5	Obesity 01/2023 - 01/2017
5	Inflammation (Inflammations) 08/2020 - 06/2017
5	Fever (Fevers) 10/2018 - 01/2014
3	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2023 - 01/2021
3	Type 2 Diabetes Mellitus (MODY) 11/2022 - 03/2013
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 03/2013
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 01/2022
2	Prediabetic State (Prediabetes) 11/2022 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2021 - 02/2014
2	Osteoarthritis 08/2020 - 01/2020
2	Pneumonia (Pneumonitis) 10/2018 - 01/2014
1	Atrial Fibrillation 05/2024
1	Overweight 01/2023
1	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2023
1	Diabetes Mellitus 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Weight Gain 01/2021
1	Graves Disease (Basedow Disease) 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Vitiligo 01/2021
1	Acne Vulgaris 01/2021
1	Skin Diseases (Skin Disease) 01/2020
1	Pathologic Processes 01/2020
1	Pituitary Neoplasms (Pituitary Adenoma) 12/2018
1	Breast Neoplasms (Breast Cancer) 12/2018
1	Anaphylaxis (Anaphylactic Shock) 10/2018
1	Viral Encephalitis 10/2018
1	Hypertension (High Blood Pressure) 08/2018
1	Thymoma (Thymic Carcinoma) 08/2018
1	Infections 12/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Glucose Intolerance 06/2017

Drug/Important Bio-Agent (IBA)

7	LipidsIBA 12/2022 - 02/2014
7	Blood Glucose (Blood Sugar)IBA 11/2022 - 03/2015
7	Insulin (Novolin)FDA Link 01/2022 - 09/2012
7	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2012
6	Triglycerides (Triacylglycerol)IBA 01/2023 - 10/2017
5	CholesterolIBA 01/2023 - 10/2017
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2015
4	Proteins (Proteins, Gene)FDA Link 06/2017 - 09/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2022 - 01/2021
3	Therapeutic UsesIBA 01/2021 - 01/2021
3	QingkailingIBA 10/2018 - 01/2014
2	oxidized low density lipoproteinIBA 01/2023 - 11/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 09/2012
2	AdiponectinIBA 01/2023 - 06/2017
2	LDL CholesterolIBA 01/2023 - 11/2022
2	HDL CholesterolIBA 01/2023 - 11/2022
2	Nonprescription Drugs (Patent Medicines)IBA 01/2021 - 01/2014
2	cinnamaldehyde (cinnamic aldehyde)FDA Link 08/2018 - 09/2012
2	Amino Acids FDA Link 07/2016 - 04/2015
1	Transfer RNA (tRNA)IBA 05/2024
1	LeptinIBA 01/2023
1	Thyroglobulin FDA Link 01/2023
1	dioscinIBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2021
1	DiosgeninIBA 01/2021
1	mangiferinIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	madecassosideIBA 01/2021
1	cinnamic acidIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 08/2020
1	Histone Deacetylase InhibitorsIBA 08/2020
1	Vorinostat FDA Link 08/2020
1	InterleukinsIBA 01/2020
1	TriterpenesIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	SaponinsIBA 01/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 12/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2018
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2018
1	ImmunosorbentsIBA 12/2017
1	EnzymesIBA 12/2017
1	AutoantibodiesIBA 12/2017
1	CurcuminIBA 12/2017
1	Pioglitazone (Actos)FDA Link 10/2017
1	Nonesterified Fatty Acids (NEFA)IBA 10/2017
1	tanshinoneIBA 09/2017
1	GlycogenIBA 08/2017
1	Plant ExtractsIBA 06/2017
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2017
1	ResistinIBA 01/2017
1	AntipyreticsIBA 03/2016
1	CarbohydratesIBA 04/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2015
1	Nucleic AcidsIBA 04/2015
1	VitaminsIBA 04/2015

Therapy/Procedure

3	Oral Administration 01/2023 - 01/2021
3	Therapeutics 01/2023 - 03/2013
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2017 - 01/2014
1	Electroacupuncture 01/2023
1	Patient Care Bundles 01/2022
1	Patient Readmission 01/2022
1	Aftercare (After-Treatment) 01/2020